There’s no shortage of big promises about AI in healthcare. The U.S. government announced a $500 billion Stargate initiative ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...

Prestigious international annual awards program recognizes standout digital health and medical technology products and ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in ...

Discover how digital innovation in clinical trial technology—eClinical platforms, remote data capture, and decentralized ...

The potential therapy for idiopathic pulmonary fibrosis is notable because not only was the small molecule discovered by ...

The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...

During a panel discussion on AI in clinical research, Prasanna Rao, Chief Products and Innovation officer at Saama emphasised the importance of making protocol data available to large language ...

Key Takeaways AI accelerates drug approvals in 2025 by streamlining clinical data analysis.Advanced AI tools reduce costs and time for new medicine development.

New diagnostic tools detect diseases at earlier stages while helping doctors personalize treatments. Medical institutions support these breakthrough tests through rigorous clinical trials and ...